Yoshiya Tanaka[Author] - Search Results

Year	Number of Results
2001	1
2002	20
2003	18
2004	18
2005	25
2006	22
2007	31
2008	19
2009	16
2010	21
2011	35
2012	61
2013	62
2014	52
2015	51
2016	65
2017	51
2018	80
2019	82
2020	96
2021	79
2022	95
2023	101
2024	84
2025	52

1

Targeted Therapies for Rheumatoid Arthritis in Super-Elderly Society: Insights From FIRST Registry, Japan.

Sonomoto K, Tanaka Y. Sonomoto K, et al. Among authors: tanaka y. Int J Rheum Dis. 2025 Apr;28(4):e70232. doi: 10.1111/1756-185X.70232. Int J Rheum Dis. 2025. PMID: 40275579 Free PMC article. Review.

2

Pursuing Precision Medicine in Managing Rheumatoid Arthritis.

Kubo S, Tanaka Y. Kubo S, et al. Among authors: tanaka y. Int J Rheum Dis. 2025 Apr;28(4):e70239. doi: 10.1111/1756-185X.70239. Int J Rheum Dis. 2025. PMID: 40269471 Free PMC article. Review.

3

Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry.

Sonomoto K, Nakayamada S, Tanaka H, Nagayasu A, Tanaka Y. Sonomoto K, et al. Among authors: tanaka y. Rheumatol Ther. 2025 Apr 21. doi: 10.1007/s40744-025-00762-w. Online ahead of print. Rheumatol Ther. 2025. PMID: 40257743 Free article.

4

Critical roles of IL-6 signaling in myoblast differentiation of human adipose-derived mesenchymal stem cells.

Otsuka T, Yamagata K, Nguyen MP, Ngo UT, Sakai H, Trimova G, Anan J, Okada Y, Nakayamada S, Tanaka Y. Otsuka T, et al. Among authors: tanaka y. Inflamm Regen. 2025 Apr 10;45(1):9. doi: 10.1186/s41232-025-00373-6. Inflamm Regen. 2025. PMID: 40211386 Free PMC article.

5

Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis.

Tanaka Y, Westhovens R, Sun H, Van der Donckt C, Zhong Y, Kaise T. Tanaka Y, et al. Rheumatol Ther. 2025 Apr 10. doi: 10.1007/s40744-025-00757-7. Online ahead of print. Rheumatol Ther. 2025. PMID: 40208566 Free article. Review.

6

Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia.

Sakamoto N, Satoh M, Ohyama K, Aibara N, Yamano Y, Kondoh Y, Morimoto S, Yamasue M, Komiya K, Kinoshita Y, Ishii H, Fujita M, Yanagi S, Shimizu T, Fukushima K, Akiyama Y, Murakami R, Tokito T, Okuno D, Ozasa M, Yura H, Kido T, Ishimoto H, Taniguchi H, Iwanaga N, Takemoto S, Takazono T, Fukahori S, Obase Y, Ishimatsu Y, Nishino T, Tanaka S, Tanaka Y, Fukuoka J, Kawakami A, Mukae H. Sakamoto N, et al. Among authors: tanaka y. J Autoimmun. 2025 Mar 28;153:103409. doi: 10.1016/j.jaut.2025.103409. Online ahead of print. J Autoimmun. 2025. PMID: 40156961

7

Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: A post hoc analysis of the OHZORA trial.

Watanabe R, Tanaka Y, Takeuchi T, Okamoto S, Kyuuma M, Matsumoto R, Nakayama Y, Katsushima M, Hashimoto M. Watanabe R, et al. Among authors: tanaka y. Rheumatology (Oxford). 2025 Mar 26:keaf171. doi: 10.1093/rheumatology/keaf171. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 40139716

8

Accelerated Type VII collagen turnover in systemic sclerosis patients, reflected by serological neo-epitope fragment biomarkers.

He Y, Sand JMB, Kubo S, Ohkubo N, Miyazaki Y, Karsdal M, Tanaka Y, Bay-Jensen AC. He Y, et al. Among authors: tanaka y. Arthritis Res Ther. 2025 Mar 19;27(1):58. doi: 10.1186/s13075-025-03525-8. Arthritis Res Ther. 2025. PMID: 40108654 Free PMC article.

9

Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: final analysis of an all-case post-marketing surveillance study.

Kuwana M, Sugiyama N, Momohara S, Atsumi T, Takei S, Tamura N, Harigai M, Fujii T, Matsuno H, Yamamoto K, Takasaki Y, Okamoto N, Takahashi N, Nakajima A, Nakajima A, Tanigawa M, Endo Y, Hirano T, Hoshi M, Mimori T, Takagi M, Tanaka S, Tanaka Y, Takeuchi T. Kuwana M, et al. Among authors: tanaka y. Mod Rheumatol. 2025 Mar 7:roaf017. doi: 10.1093/mr/roaf017. Online ahead of print. Mod Rheumatol. 2025. PMID: 40053522

10

Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross-Sectional Study.

Torimoto K, Okada Y, Mita T, Tanaka K, Sato F, Katakami N, Yoshii H, Nishida K, Tanaka Y, Ishii R, Gosho M, Shimomura I, Watada H. Torimoto K, et al. Among authors: tanaka y. J Diabetes. 2025 Mar;17(3):e70065. doi: 10.1111/1753-0407.70065. J Diabetes. 2025. PMID: 40049179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,049 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,049 results

Results by year